6 results
To assess the analgesic effect of ARA290 in chronic pain patients
To measure the PK of ARA290 when given in de SQ form
In this study we will assess the effect of ARA290 on nerve damage by taking 4 skin bipsies during treatment.
ARA290 is a new drug against neuropathic pain and was succesfully tested in previous studies on patients with neuropathic pain due to diabetes and sarcoidosis. The current study involves sarcoidosis patients with pain due to neuropathy. The purpose…
To measure the plasma conc. of ARA 290 in healthy volunteers
The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease) with an experimental oral study drug named eliglustat in pediatric patients from 2 to 18 years with Gaucher disease.